Susquehanna International Group, LLP Geo Vax Labs, Inc. Transaction History

Susquehanna International Group, LLP

  • $560 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 16, 2023
SELL
$0.62 - $1.11 $17,098 - $30,611
-27,578 Reduced 67.33%
13,383 $8,000
Q4 2022

Feb 14, 2023
BUY
$0.55 - $17.1 $22,528 - $700,433
40,961 New
40,961 $25,000
Q1 2022

May 16, 2022
SELL
$17.25 - $58.95 $198,323 - $677,748
-11,497 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$52.65 - $71.7 $605,317 - $824,334
11,497 New
11,497 $42,000

About GeoVax Labs, Inc.

GOVX Quotes by TradingView
  • Ticker GOVX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 24,744,000
  • Market Cap $73M
  • Description
  • GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and cancers using modified vaccinia ankara virus-like particle vaccine platform. It is developing various preventive vaccines against (COVID-19), human immunodeficiency virus (HIV); Zika virus; malaria; and hemorrhag...
More about GOVX
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email